Current Opinion in Pharmacology

Article	Citations
Recent advances in emerging PCOS therapies	64
Metabolic comorbidities of adrenal insufficiency: Focus on steroid replacement therapy and chronopharmacology	63
Interrogating the function of GABAA receptors in the brain with optogenetic pharmacology	59
Novel strategies to promote resolution of inflammation to treat lower extremity artery disease	54
The P2X7 purinoceptor in pathogenesis and treatment of dystrophino- and sarcoglycanopathies	48
Editorial overview: Immune regulation and cancers	47
Editorial Board	45
Established and novel human translational models to advance cystic fibrosis research, drug discovery, and optimize CFTR-targeting therapeutics	42
Routine neoadjuvant chemotherapy for all patients with resectable pancreatic ductal adenocarcinoma? A review of the evidence	41
Editorial overview – 2022 respiratory issue: Cystic fibrosis pathophysiology, models, and novel therapies	40
Impact of amino acids on microglial activation and CNS remyelination	37
The role of extracellular ATP in homeostatic immune cell migration	35
Editorial Board	32
Lipid raft disruption as an opportunity for peripheral analgesia	32
Estrogen related receptor alpha: Potential modulator of age-related macular degeneration	31
Editorial Board	31
Editorial overview: “Purinergic immune cell regulation reveals novel pharmacological targets”	30
Organotypic human ex vivo models for coronavirus disease 2019 research and drug development	29
Host membrane proteins in the HIV-induced membrane fusion: Role in pathogenesis and therapeutic potential of autoantibodies	29
Editorial Board	28
Shaping DNA damage responses: Therapeutic potential of targeting telomeric proteins and DNA repair factors in cancer	27
Quantitative assessment of volumetric muscle loss: Dual-energy X-ray absorptiometry and ultrasonography	26
From “contraindicated” to “first line” – Current mechanistic insights beyond canonical β-receptor signaling	25
Drug effects on neuropeptides and their receptors: Big hopes but moderate success in the treatment of chronic pain	25
Non-alcoholic fatty liver disease: Current therapeutic options	25

MicroRNA: A mediator of diet-induced cardiovascular protection	25
Dietary serine supplementation: Friend or foe?	24
Beyond the AMPA receptor: Diverse roles of SynDIG/PRRT brain-specific transmembrane proteins at excitatory synapses	24
Splice-switching as cancer therapy	23
Nutraceuticals in mental diseases — Bridging the gap between traditional use and modern pharmacology	23
The 2013–2016 Ebola virus disease outbreak in West Africa	23
Stress, kisspeptin, and functional hypothalamic amenorrhea	22
Nutraceuticals use and type 2 diabetes mellitus	22
New CARs on and off the road: challenges and new developments in CAR-T cell therapy	21
Current pharmacological treatment of hepatocellular carcinoma	21
Role of metformin and other metabolic drugs in the prevention and therapy of endocrine-related cancers	21
Emerging drugs for the treatment of primary sclerosing cholangitis	21
Circulating factors that influence the central nervous system remyelination	21
Metabolic regulation of tissue-resident memory CD8+ T cells	21
Pharmacologic treatment of gastroparesis: What is (still) on the horizon?	20
Photopharmacological control of cell signaling with photoswitchable lipids	20
Native botulinum toxin type A vs. redesigned botulinum toxins in pain: What did we learn so far?	19
Targeting the soluble epoxide hydrolase pathway as a novel therapeutic approach for the treatment of pain	18
Elexacaftor–tezacaftor–ivacaftor: The new paradigm to treat people with cystic fibrosis with at least one p.Phe508del mutation	17
Integrating network pharmacology: The next-generation approach in ocular drug discovery	17
Hormonal drugs for the treatment of endometriosis	17
Gestational diabetes: Implications for fetal growth, intervention timing, and treatment options	17
N-methyl-d-aspartate receptor function in neuronal and synaptic development and signaling	17
The active kinome: The modern view of how active protein kinase networks fit in biological research	17
Photoswitchable allosteric modulators for metabotropic glutamate receptors	17
How organoids can improve personalized treatment in patients with gastro-esophageal tumors	17
Prospects for COPD treatment	17
The blood pressure lowering effects of glucagon-like peptide-1 receptor agonists: A mini-review of the potential mechanisms	17
Tropical fruits from Australia as potential treatments for metabolic syndrome	17
Interventional functional diagnostics in gastrointestinal endoscopy: Combining diagnostic and therapeutic tools in the endoscopy suite with the functional lumen imaging probe	17
Corrigendum to ‘JAK inhibitors: Current position in treatment strategies for use in inflammatory bowel disease’	17
Chronotherapy of cardiac and vascular disease: timing medications to circadian rhythms to optimize treatment effects and outcomes	16
Disease-modifying therapies in short bowel syndrome	16
Corticosteroids and circadian rhythms in the cardiovascular system	16
New developments in treatments for systemic vasculitis	16
Highlighting vulnerabilities in the alternative lengthening of telomeres pathway	16
Adenosine signaling as target in cardiovascular pharmacology	16
Targeting the altered duodenal microenvironment in functional dyspepsia	15
Targeting fibroblast-like synoviocytes in rheumatoid arthritis	15
Remyelinating strategies: What can be learned from normal brain development	15
Considerations for individualized first-line systemic treatment in advanced hepatocellular carcinoma	15
Editorial Board	15
Polyphenols affect the humoral response in cancer, infectious and allergic diseases and autoimmunity by modulating the activity of TH1 and TH2 cells	15
Editorial overview: COVID-19 therapy: From lung disease to systemic disorder	14
Editorial overview: Endocrine and metabolic diseases (2023)	14
Gastrointestinal issue: Advances in gastrointestinal oncology	14
Cancer 2021: New therapeutic approaches for the treatment of cancer — building on advances in cancer biology and the molecular genetics of cancer	14
Functional role of the ER stress transducer IRE1α in CF airway epithelial inflammation	14
Editorial Board	14
A computational overview on phylogenetic characterization, pathogenic mutations, and drug targets for Ebola virus disease	14

Technological advancements to study cellular signaling pathways in inherited retinal degenerative diseases	13
Antibiotics, the microbiome and gastrointestinal cancers: A causal interference?	13
Targeting the NRF2 pathway: A promising approach for corneal endothelial dysfunction	13
Nonsteroidal mineralcorticoid receptor antagonists: Novel therapeutic implication in the management of patients with type 2 diabetes	13
Editorial Board	13
From serendipity to rational drug design in brain disorders: in silico, in vitro, and in vivo approaches	13
Optofluidic neural interfaces for in vivo photopharmacology	13
Recent developments and strategies of Ebola virus vaccines	13
Practical application of breath tests in disorders of gut–brain interaction	13
Targeting intramuscular adipose tissue expansion to preserve contractile function in volumetric muscle loss: A potentially novel therapy?	13
Artemisinins and their impact on inhibitory neurotransmission	13
Editorial overview: Neuroscience: Advances in the field	13
Bioprinted nanocomposite hydrogels: A proposed approach to functional restoration of skeletal muscle and vascular tissue following volumetric muscle loss	13
The complement pathway as a therapeutic target for neovascular age-related macular degeneration-mediated subretinal fibrosis	13
The hypodopaminergic state ten years after: transcranial magnetic stimulation as a tool to test the dopamine hypothesis of drug addiction	12
Current status of hepatitis delta	12
Photo-isomerizable tweezers to probe ionotropic receptor mechanisms	12
Hepatic arterial infusion chemotherapy for patients with hepatocellular carcinoma: Applicability in Western countries	12
Applications of chemogenetics in non-human primates	12
Targeting drug memory reconsolidation: a neural analysis	12
Purinergic signalling in graft-versus-host disease	12
Astrocytes as cellular mediators of cue reactivity in addiction	12
Optic nerve regeneration: Potential treatment approaches	12
Type 2 diabetic women are not small type 2 diabetic men: Sex-and-gender differences in antidiabetic drugs	12
The potential pharmacological mechanisms of β-hydroxybutyrate for improving cognitive functions	12
Adoptive cell therapy for solid tumors: Chimeric antigen receptor T cells and beyond	11
The potential role of oxytocin in addiction: What is the target process?	11
Therapeutic strategies for treating juvenile idiopathic arthritis	11
Role of HSV-1 in Alzheimer's disease pathogenesis: A challenge for novel preventive/therapeutic strategies	11
Analgesic potential of voltage gated sodium channel modulators for the management of pain	11
Health benefits of spices in individuals with chemotherapeutic drug-induced cardiotoxicity	11
Light-activated receptor tyrosine kinases: Designs and applications	11
The regulatory roles of dietary fibers on host health via gut microbiota-derived short chain fatty acids	11
Modafinil and its structural analogs as atypical dopamine uptake inhibitors and potential medications for psychostimulant use disorder	11
RAD51 paralogs: Expanding roles in replication stress responses and repair	11
Genetic risk scores and personalization of care in fatty liver disease	11
Pancreatic alpha cells and glucagon secretion: Novel functions and targets in glucose homeostasis	11
Editorial overview: Special issue on “Rheumatology: Therapeutic advances for autoimmune and musculoskeletal diseases”	10
Neuroinflammation in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection: Pathogenesis and clinical manifestations	10
Therapeutic innovations for geographic atrophy: A promising horizon	10
Immune tolerance therapies for autoimmune diseases: Shifting the goalpost to cure	10
Photopharmacology for vision restoration	10
Advances in lupus therapeutics: Achieving sustained control of the type I interferon pathway	10
Pharmacologic approaches to prevent skeletal muscle atrophy after spinal cord injury	10
Corrigendum to “Metformin: Still the sweet spot for CV protection in diabetes?” [Curr Opin Pharmacol 54 (2020) 202–208]	10
Effects of protein glycation and protective mechanisms against glycative stress	10
Three-dimensional perspective on ryanodine receptor mutations causing skeletal and cardiac muscle-related diseases	10
Biased signalling in analgesic research and development	9
The pleiotropic roles of autophagy in Alzheimer's disease: From pathophysiology to therapy	9
Advances in antiobesity mechanisms of capsaicin	9
Choosing the right drug: status and future of endocannabinoid research for the prevention of drug-seeking reinstatement	9
Fluorescent chemigenetic actuators and indicators for use in living animals	9
Three-dimensional culture models to study glioblastoma — current trends and future perspectives	9
Nanotechnology in pulmonary medicine	9
Priming metabolism with the type 5 phosphodiesterase: the role of cGMP-hydrolyzing enzymes	9
Emerging mutations in the SARS-CoV-2 variants and their role in antibody escape to small molecule-based therapeutic resistance	9
Editorial Board	9
Towards eradication of HBV: Treatment approaches and status of clinical trials	9
TMEM16A (ANO1) as a therapeutic target in cystic fibrosis	9
Pharmaceutical therapies targeting autophagy for the treatment of age-related macular degeneration	9
Management of blood pressure disorders in individuals with spinal cord injury	9
Role of O-linked N-acetylglucosamine (O-GlcNAc) modification of proteins in diabetic cardiovascular complications	9
Circadian influence on inflammatory response during cardiovascular disease	9
Dementia therapeutics and cognitive rehabilitation	8
Immune dysfunction after spinal cord injury – A review of autonomic and neuroendocrine mechanisms	8
Reviewing the toolbox for degrader development in oncology	8
Eosinophilic esophagitis: New molecules, better life?	8
The role of Pannexin-1 channels, ATP, and purinergic receptors in the pathogenesis of HIV and SARS-CoV-2	8
Spinal and bulbar muscular atrophy: From molecular pathogenesis to pharmacological intervention targeting skeletal muscle	8
Editorial overview: Introduction to the musculoskeletal section of current opinion in pharmacology	8
Editorial Board	8
Editorial Board	8
MedXercise: a promising strategy to promote remyelination	8
Targeting cAMP signaling compartments in iPSC-derived models of cardiovascular disease	8
Targeting the endocannabinoid system for the management of low back pain	8
Publisher’s Note	8
PRRT for higher-grade neuroendocrine neoplasms: What is still acceptable?	8
The expanding role of split protein complementation in opsin-free optogenetics	8
Cardiac circadian rhythms in time and space: The future is in 4D	8
Nicotinamide mononucleotide: An emerging nutraceutical against cardiac aging?	8

AI-driven GPCR analysis, engineering, and targeting	8
Publisher Note - Virtual Special Issue	8
Low FODMAP diet beyond IBS: Evidence for use in other conditions	8
The role of extracellular ATP and P2X receptors in the pathogenesis of HIV-1	7
Precision medicine in idiopathic pulmonary fibrosis therapy: From translational research to patient-centered care	7
Drug repurposing in skeletal muscle ion channelopathies	7
Environmental enrichment-inspired pharmacological tools for the treatment of addiction	7
KRAS inhibition in metastatic colorectal cancer: An update	7
Novel treatments for dry eye syndrome	7
Purinergic signaling pathway in severe COVID-19	7
Preclinical pharmacology modeling of chimeric antigen receptor T therapies	7
Dyslipidemia and diabetes mellitus: Role of lipoprotein species and interrelated pathways of lipid metabolism in diabetes mellitus	7
Novel treatments in multidrug-resistant tuberculosis	7
Systemic inflammation after spinal cord injury: A review of biological evidence, related health risks, and potential therapies	7
Treatments targeting the luminal gut microbiota in patients with irritable bowel syndrome	7
Update on anti-fibrotic pharmacotherapies in skeletal muscle disease	7
The use of hormone stimulation in male infertility	7
NMR applications to GPCR recognition by peptide ligands	7
A review of emerging neuroprotective and neuroregenerative therapies in traumatic spinal cord injury	7
CFTR RNA- and DNA-based therapies	7
Modulating regulatory T cell migration in the treatment of autoimmunity and autoinflammation	7
Genome structure and genetic diversity in the Ebola virus	7
Optical control of Class A G protein-coupled receptors with photoswitchable ligands	6
Treatment of early rheumatoid arthritis: Methotrexate and beyond	6
Exercise as a drug for glucose management and prevention in type 2 diabetes mellitus	6
Animal models of cystic fibrosis in the era of highly effective modulator therapies	6
Lynx1 prototoxins: critical accessory proteins of neuronal nicotinic acetylcholine receptors	6
COVID-19 and retinal degenerative diseases: Promising link “Kaempferol”	6
Advances in tethered photopharmacology for precise optical control of signaling proteins	6
Gastrointestinal manifestations and SARS-CoV-2 infection	6
Dysregulation of immune checkpoint proteins in hepatocellular carcinoma: Impact on metabolic reprogramming	6
Corrigendum to “Antihypertensive effect of soybean bioactive peptides: A review” [Curr Opin Pharmacol (62) (2022) 74–81]	6
Role of specific CDKs in regulating DNA damage repair responses and replication stress	6
Pharmacology of pannexin channels	6
Targeting KNDy neurons to control GnRH pulses	6
The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: A target for new therapies against cardiovascular diseases	6
Caffeine consumption and schizophrenia: A highlight on adenosine receptor–independent mechanisms	6